Incidence of depression related to isotretinoin treatment in 100 ACNE vulgaris patients

Psychological Reports

Volumn 99, Issue 3, 2006, Pages 897-906

  Kaymak, Yeşim ^a,b   Kalay, Mustafa ^a   Ilter, Nilsel ^a   Taner, Ender ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846807746     PISSN: 00332941     EISSN: 1558691X     Source Type: Journal    
DOI: 10.2466/PR0.99.3.897-906     Document Type: Review

References (32)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders (DSM-III). (3rd ed.) Washington, DC: American Psychiatric Association, 1980.
2. BICKERS, D. R., & SAURAT, J. H. Isotretinoin: a state-of-the-art conference. Journal of the American Academy of Dermatology, 2001, 45, 125-128.
3. BIGBY, M., & STERN, R. S. Adverse reactions to isotretinoin: a report from the Adverse Drug Reaction Reporting System. Journal of the American Academy of Dermatology, 1988, 18, 543-552.
4. BREMNER, J. D., FANI, N., ASHRAF, A., VOTAW, J. R., BRUMMER, M. E., CUMMINS, T., VACCARINO, V., GOODMAN, M. M., REED, L., SIDDIG, S., & NEMEROFF, C. B. Functional brain imaging alterations in acne patients treated with isotretinoin. American Journal of Psychiatry, 2005, 162, 983-991.
5. BROCQ, L., & JACQUET, L. Notes pour servir a l'histoire des neurodermites: du lichen circumscriptes des anciens auters, ou lichen simplex chronique de M. le Dr. E. Vidal. Annales de Dermatologie et de Syphiligraphie (Paris) 1891, 97, 193.
6. BYRNE, A., & HNATKO, G. Depression associated with isotretinoin therapy. Canadian Journal of Psychiatry, 1995, 40, 567.
7. CITROME, L. Safety of Accutane with possible depression. Postgraduate Medicine, 1998, 104, 38.
8. CUNLIFFE, W. J. Management of adult acne and acne variants. Journal of Cutaneous Medical Surgery, 1998, 2(Suppl. 3), 7-13.
9. ELLIS, C. N., & KRACH, K. J. Uses and complications of isotretinoin therapy. Journal of the American Academy of Dermatology, 2001, 45, 150-157.
10. ENDERS, S. J., & ENDERS, J. M. Isotretinoin and psychiatric illness in adolescents and young adults. The Annals of Pharmacotherapy, 2003, 37, 1124-1127.
11. GOODMAN, A. B. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95, 7240-7244.
12. GUPTA, M. A., & GUPTA, A. K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology, 1998, 139, 846-850.
13. GUPTA, M. A., GUPTA, A. K., SCHORK, N. J., ELLIS, C. N., & VOORHEES, J. J. Psychiatric aspects of the treatment of mild to moderate facial acne. International Journal of Dermatology, 1990, 29, 719-721.
14. HAMILTON, M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 1960, 23, 56-62.
15. HEALY, E., & SIMPSON, N. Acne vulgaris. British Medical Journal, 1994, 308, 831-833.
16. HERSOM, K., NEARY, M. P., LEVAUX, H. P., KLASKALA, W., & STRAUSS, J. S. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. Journal of the American Academy of Dermatology, 2003, 49, 424-432.
17. JACOBS, D. G., DEUTSCH, N. L., & BREWER, M. Suicide, depression, and isotretinoin: is there a causal link? Journal of the American Academy of Dermatology, 2001, 45, 168-175.
18. JENTSCH, J. D., ROTH, R. H., & TAYLOR, J. R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Progress in Brain Research, 2000, 126, 433-453.
19. JICK, S. S., KREMERS, H. M., & VASILAKIS- SCARAMOZZA, C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Archives of Dermatology, 2000, 136, 1231-1236.
20. JOHANN, V., JELIAZNIK, N., SCHRAGE, K., & MEY, J. Retinoic acid downregulates the expression of ciliary neurotrophic factor in rat Schwann cells. Neuroscience Letters, 2003, 339, 13-16.
21. JOWETT, S., & RYAN, T. Skin diseases and handicap: an analysis of the impact of skin conditions. Social Science & Medicine, 1985, 20, 425-429.
22. KELLETT, S. C., & GAWKRODGER, D. J. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology, 1999, 140, 273-282.
23. KESSLER, R. C., MCGONAGLE, K. A., ZHAO, S., NELSON, C. B., HUGHES, M., ESHLEMAN, S., WITTCHEN, H. V., & KENDLER, K. S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Archives of General Psychiatry, 1994, 51, 8-19.
24. KREZEL, W., GHYSELINCK, N., SAMAD, T. A., DUPE, V., KASTNER, P., BORRELLI, E., & CHAMBON, P. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science, 1998, 279(5352), 863-867.
25. MCCAFFERY, P., & DRAGER, U. C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91, 7772-7776.
26. MCLANE, J. Analysis of common side effects of isotretinoin. Journal of the American Academy of Dermatology, 2001, 45, 188-194.
27. MEDANSKI, R. S., & HANDLER, R. M. Dermatopsychosomatics: classification, physiology, and therapeutic approaches. Journal of the American Academy of Dermatology, 1981, 5, 125-136.
28. NEWTON, J. N., MALLON, E., KLASSEN, A., RYAN, T. J., & FINLAY, A. Y. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. British Journal of Dermatology, 1997, 137, 563-567.
29. RISCH, S. C., & NEMEROFF, C. B. Neurochemical alterations of serotonergic neuronal systems in depression. The Journal of Clinical Psychiatry, 1992, 53, 3-7.
30. RUBINOW, D. R., PECK, G. L., SQUILLACE, K. M., & GANTT, G. G. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. Journal of the American Academy of Dermatology, 1987, 17, 25-32.
31. SCHEINMAN, P. L., PECK, G. L., RUBINOW, D. R., DIGIOVANNA, J. J., ABANGAN, D. L., & RAVIN, P. D. Acute depression from isotretinoin. Journal of the American Academy of Dermatology, 1990, 22, 1112-1114.
32. WYSOWSKY, D. K., PITTS, M., & BEITZ, J. Depression and suicide in patients treated with isotretinoin. The New England Journal of Medicine, 2001, 344-460.